Literature DB >> 24056860

IL-17A RNA aptamer: possible therapeutic potential in some cells, more than we bargained for in others?

Rosella Doble1, Michael F McDermott2, Özlem Cesur1, Nicola J Stonehouse1, Miriam Wittmann3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24056860     DOI： 10.1038/jid.2013.399

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  10 in total

1.  Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins.

Authors:  E Basner-Tschakarjan; A Mirmohammadsadegh; A Baer; U R Hengge
Journal:  Gene Ther       Date:  2004-05       Impact factor: 5.250

2.  Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus.

Authors:  Mark Ellingham; David H J Bunka; David J Rowlands; Nicola J Stonehouse
Journal:  RNA       Date:  2006-10-03       Impact factor: 4.942

3.  Primary human keratinocytes efficiently induce IL-1-dependent IL-17 in CCR6+ T cells.

Authors:  Philipp Muhr; Julius Renne; Verena Schaefer; Thomas Werfel; Miriam Wittmann
Journal:  Exp Dermatol       Date:  2010-08-31       Impact factor: 3.960

4.  A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

Authors:  E Merit Reyes-Reyes; Yun Teng; Paula J Bates
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

5.  Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.

Authors:  Akira Ishiguro; Taishin Akiyama; Hironori Adachi; Jun-ichiro Inoue; Yoshikazu Nakamura
Journal:  Arthritis Rheum       Date:  2011-02

6.  Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors.

Authors:  J Huang; J Moore; S Soffer; E Kim; D Rowe; C A Manley; K O'Toole; W Middlesworth; C Stolar; D Yamashiro; J Kandel
Journal:  J Pediatr Surg       Date:  2001-02       Impact factor: 2.545

Review 7.  The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.

Authors:  David A Martin; Jennifer E Towne; Gregory Kricorian; Paul Klekotka; Johann E Gudjonsson; James G Krueger; Chris B Russell
Journal:  J Invest Dermatol       Date:  2012-06-07       Impact factor: 8.551

8.  IL-27 Regulates IL-18 binding protein in skin resident cells.

Authors:  Miriam Wittmann; Rosella Doble; Malte Bachmann; Josef Pfeilschifter; Thomas Werfel; Heiko Mühl
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

9.  An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein.

Authors:  Clare Nicol; Özlem Cesur; Sophie Forrest; Tamara A Belyaeva; David H J Bunka; G Eric Blair; Nicola J Stonehouse
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

10.  Current progress of RNA aptamer-based therapeutics.

Authors:  Jiehua Zhou; Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Front Genet       Date:  2012-11-02       Impact factor: 4.599
  10 in total
  4 in total

1.  The Subcellular Localisation of the Human Papillomavirus (HPV) 16 E7 Protein in Cervical Cancer Cells and Its Perturbation by RNA Aptamers.

Authors:  Özlem Cesur; Clare Nicol; Helen Groves; Jamel Mankouri; George Eric Blair; Nicola J Stonehouse
Journal:  Viruses       Date:  2015-06-26       Impact factor: 5.048

2.  An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein.

Authors:  Tamara A Belyaeva; Clare Nicol; Ozlem Cesur; Gilles Travé; George Eric Blair; Nicola J Stonehouse
Journal:  Cancers (Basel)       Date:  2014-07-24       Impact factor: 6.639

3.  Antimicrobial Peptide LL-37 Facilitates Intracellular Uptake of RNA Aptamer Apt 21-2 Without Inducing an Inflammatory or Interferon Response.

Authors:  Tom Macleod; Joseph Ward; Adewonuola A Alase; Charlie Bridgewood; Miriam Wittmann; Nicola J Stonehouse
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

4.  Inhibition of the foot-and-mouth disease virus subgenomic replicon by RNA aptamers.

Authors:  Sophie Forrest; Zoe Lear; Morgan R Herod; Martin Ryan; David J Rowlands; Nicola J Stonehouse
Journal:  J Gen Virol       Date:  2014-08-05       Impact factor: 3.891
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.